Key result
Molecular imaging with targeted tracers may improve post-MI prognosis and treatment by visualizing HF biological processes.
Why the study?
Current imaging modalities do not characterise the exact biological mechanisms involved in adverse post-MI remodeling or stage disease progression.
Molecular imaging using specific tracers offers the potential to visualize and quantify the biological mechanisms of post-MI remodeling, aiding in prognosis and targeted treatment.
Should not yet change post-MI imaging practice; leaves open molecular tracers' prognostic value pending prospective trials.
Myocardial infarction (MI) is a leading cause of mortality, affecting 3.8% of the global population under 60 years of age, and 9.5% over 60 years. Adverse post-MI remodeling is the main contributor to heart failure, conferring a three to six-fold increase in risk of premature death. Current imaging modalities such as nuclear imaging and magnetic resonance imaging provide structural and functional information of the heart, and identify extracellular expansion for indirect estimation of infarct size. However, they do not characterise the exact biological mechanisms involved, nor staging of disease progression. Molecular imaging aims to visualise the underlying processes of remodeling at a molecular and cellular level, aiding more accurate prognosis and targeted treatment. Molecular tracers, such as radioisotopes and paramagnetic nanoparticles, are modified to adhere to specific molecules or cells involved in inflammation, angiogenesis and scar formation, which can be visualised and quantitatively assessed using positron-emission tomography and magnetic resonance imaging. This article provides an overview of the pathophysiology of adverse remodeling, the latest molecular contrast agents under development, and future directions for integration into clinical practice.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2026) conducted a review in Myocardial infarction and post-infarct cardiac remodeling. Molecular contrast agents was evaluated. Molecular contrast agents, such as radioisotopes and paramagnetic nanoparticles, aim to visualize the underlying processes of post-infarct cardiac remodeling at a molecular and cellular level.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: